ANXA2 and pancreatic neoplasm: We discovered that in pancreatic cancer, LINC00941 acts as a protein decoy in the cytoplasm and confirmed that it can competitively bind to the E3 ubiquitin ligase NEDD4L to inhibit the ubiquitination of ANXA2 and promote its stabilization.